Latest Revenue Growth News

Stockland has reported a robust half-year performance for 1H26, with revenue climbing 23.2% and funds from operations up nearly 30%, driven by strong growth in Masterplanned Communities and strategic partnerships.

GWA Group Limited reported solid half-year growth in revenue and earnings, driven by volume gains and strategic initiatives including a new AI partnership. The company also lifted its interim dividend, signalling confidence despite mixed market conditions ahead.

oOh!media has reported solid earnings growth and a higher dividend for 2025, maintaining its leadership in the Out of Home advertising market despite a softer second half. Major contract wins, including Transurban motorway assets, underpin its positive outlook for 2026.

Dataworks Group Limited has reached a significant milestone, turning cash flow positive in the second quarter of FY26, supported by over $30 million in secured government contracts and a robust global pipeline for its centralised self-exclusion technology.

Fiducian Group’s FY2026 half-year results reveal robust growth with a 9% rise in funds under management and a 17% jump in underlying net profit, despite ongoing regulatory challenges.

The GPT Group has reported a remarkable financial turnaround for FY2025, posting a 264% increase in total revenues and declaring a 12 cent distribution per stapled security. This strong performance signals renewed confidence in the property trust’s operational strategy.

BlueScope Steel reported a robust first half of FY2026 with underlying EBIT soaring 81% to $557.5 million and announced a $3.00 per share shareholder return plan, while decisively rejecting a $30 per share takeover proposal.

The a2 Milk Company has reported robust half-year results with strong revenue and earnings growth, driven by gains in infant formula and liquid milk segments, alongside a strategic supply chain transformation. The company has upgraded its full-year outlook and announced a substantial special dividend, signalling confidence in its growth trajectory.

AVITA Medical reported a mixed fourth quarter with revenue pressures easing and full-year growth, underpinned by a new $60 million credit facility and advancing clinical trials.

AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.